Discussion about this post

User's avatar
Mike Williams's avatar

"Low cost-effectiveness (~$200,000 CAD per hospitalization prevented), and administrative issues may have impacted the program."

"...assumed effectiveness of Palivizumab at 30%..."

Is that newspeak for modelled assumption which failed?

At $200K a baby..

So for every 10 babies they achieve "assumed effectiveness" for 3.

Which means 10 babies times $200K is $2 Million

For an "assumed effectiveness" for 3.

Wow..nothing to see here folks..

Expand full comment
IPA's avatar
Feb 23Edited

Seems to be a very "1984" style of approach to heath care decisions. It would be nice to know if these interventions were actually safe and beneficial. I'm now 82, (COVID) unvaccinated and have never been sick with even a cold since the onset of the "pandemic." As far as I know I'm not included in any statistics.

Expand full comment
71 more comments...

No posts